Avid Bioservices Inc (CDMO)

[Couch]

Rob Garnick: That’s a really good point. A lot of companies have actually stumbled in the past because they had a drug that worked but they weren’t able to produce the satisfactory commercial supply. But we certainly have size & designs planned in order to produce both the launch capability and actually out a number of years in the expansion of the drug into the marketplace. So, I agree with Steve, I think we should be so lucky as to have the problem of having to build another plant - that would be out good doing.